Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Research graph
References from Diagnostic Utility of SS18-SSX Fusion-Specific and SSX C-Terminus Antibodies in Synovial Sarcoma: Validation in a Large Indian Tertiary Care Cohort. Local targets link to admitted publications; unresolved targets remain external evidence.
Outcome of chemotherapy in advanced synovial sarcoma patients: review of 15 clinical trials from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
10.1016/j.ejca.2016.02.002 · 2016 · External reference
Synovial sarcoma
10.1016/s1092-9134(98)80042-7 · 1998 · External reference
Synovial sarcoma: defining features and diagnostic evolution
10.1016/j.anndiagpath.2014.09.002 · 2014 · External reference
Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma
10.1038/ng0894-502 · 1994 · External reference
Reversible disruption of mSWI/SNF (BAF) complexes by the SS18-SSX oncogenic fusion in synovial sarcoma
10.1016/j.cell.2013.02.036 · 2013 · External reference
Detection of SS18-SSX fusion transcripts in formalin-fixed paraffin-embedded neoplasms: analysis of conventional RT-PCR, qRT-PCR, and dual color FISH as diagnostic tools for synovial sarcoma
10.1038/modpathol.3800761 · 2007 · External reference
Clinicopathologic prognostic factors in synovial sarcoma: a retrospective analysis of 40 patients
2008 · External reference
Validation of immunohistochemistry for detection of SS18-SSX fusion proteins in synovial sarcoma
2020 · External reference
Validation of the rabbit monoclonal SS18-SSX fusion protein antibody in the diagnosis of synovial sarcoma: an Australian study
2020 · External reference
SS18-SSX fusion-specific antibody is a useful diagnostic marker for synovial sarcoma: a validation study with a new diagnostic algorithm proposal
2023 · External reference
Diagnostic value of the SS18-SSX fusion-specific antibody in synovial sarcoma: a large series from the French Sarcoma Group
2021 · External reference
Detection of the SS18-SSX fusion protein in synovial sarcoma with a novel immunohistochemical antibody: a useful tool for the diagnosis of pulmonary metastasis
2021 · External reference
Use of SS18-SSX fusion-specific antibody in the diagnosis of synovial sarcoma: a study of 36 cases and review of the literature
2021 · External reference
Expanding the phenotype of mesenchymal tumors harboring the EWSR1-CREB family fusions: a new series of 20 genetically confirmed cases
2022 · External reference
Diagnostic accuracy of the SS18-SSX fusion-specific antibody in synovial sarcoma
2020 · External reference
Chromosome instability accounts for reverse metastatic outcomes of pediatric and adult synovial sarcomas
10.1200/jco.2012.46.0147 · 2013 · External reference
Delivery of affordable and equitable cancer care in India
10.1016/s1470-2045(14)70117-2 · 2014 · External reference
Utility of immunohistochemistry with antibodies to SS18-SSX chimeric proteins and C-terminus of SSX protein for synovial sarcoma differential diagnosis
10.1097/pas.0000000000002144 · 2024 · External reference